10x Genomics (TXG) Change in Account Payables (2018 - 2026)

10x Genomics has disclosed Change in Account Payables across 9 years of filings, most recently posting $3.3 million for Q2 2026.

• In Q2 2026, Change in Account Payables fell 45.48% year-over-year to $3.3 million; the TTM figure through Jun 2026 stood at $2.5 million (up 144.12% YoY), while the FY2025 annual figure was -$2.1 million, up 36.61% from the prior year.
• Change in Account Payables came in at $3.3 million for Q2 2026 at 10x Genomics, down from $4.8 million in the prior quarter.
• In the past five years, Change in Account Payables ranged from a high of $7.4 million in Q2 2022 to a low of -$13.4 million in Q4 2024.
• Average Change in Account Payables over 5 years is $135166.7, with a median of $463000.0 recorded in 2024.
• Year-over-year, Change in Account Payables soared 729.22% in 2022 and sank 1331.25% in 2023.
• Over 5 years, Change in Account Payables stood at -$224000.0 in 2022, then slumped by 1331.25% to -$3.2 million in 2023, then sank by 317.9% to -$13.4 million in 2024, then soared by 59.56% to -$5.4 million in 2025, then jumped by 160.72% to $3.3 million in 2026.
• Per Business Quant data, the three most recent Change in Account Payables figures were $3.3 million in Q2 2026, $4.8 million in Q1 2026, and -$5.4 million in Q4 2025.